X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-24 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.06 | -7,772 | 0 | -100% | -$140,360 | |||||
| D | 2024-07-18 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.20 | -12,625 | 0 | -100% | -$229,804 | |||||
| DM | 2024-07-12 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.02 | -9,189 | 0 | -100% | -$165,578 | |||||
| DM | 2024-07-01 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.01 | -912 | 0 | -100% | -$16,428 | |||||
| D | 2024-06-24 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.19 | -9,260 | 0 | -100% | -$168,427 | |||||
| DM | 2024-06-11 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.06 | -1,586 | 0 | -100% | -$28,637 | |||||
| DM | 2024-06-05 | PEPG | Mellion Michelle L | SVP, Clinical Development | S - Sale+OE | $18.08 | -8,656 | 0 | -100% | -$156,460 | |||||
2024-05-17 | PEPG | Svenstrup Niels | SVP, Chem. Mfg, Controls | S - Sale | $13.41 | -10,000 | 0 | -100% | -$134,100 | ||||||
| A | 2022-05-10 | PEPG | Oxford Science Enterprises Plc | 10% | P - Purchase | $12.00 | +879,970 | 4,755,388 | +23% | +$10,559,640 | |||||
2024-02-09 | PEPG | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $10.64 | +2,557,593 | 10,689,545 | +31% | +$27,212,790 | ||||||
2023-11-30 | PEPG | McArthur James G | Pres, CEO | P - Purchase | $4.17 | +1,694 | 1,694 | New | +$7,056 | ||||||
| D | 2023-06-08 | PEPG | McArthur James G | Pres, CEO | S - Sale+OE | $16.04 | -2,381 | 0 | -100% | -$38,188 | |||||
| DM | 2023-06-06 | PEPG | McArthur James G | Pres, CEO | S - Sale+OE | $16.19 | -26,569 | 0 | -100% | -$430,277 | |||||
| DM | 2023-06-02 | PEPG | McArthur James G | Pres, CEO | S - Sale+OE | $16.04 | -2,300 | 0 | -100% | -$36,891 | |||||
| D | 2023-03-24 | PEPG | Goyal Jaya | EVP, Res., Preclin. Dev. | S - Sale+OE | $20.00 | -392 | 0 | -100% | -$7,840 | |||||
| DM | 2023-02-06 | PEPG | Goyal Jaya | EVP, Res., Preclin. Dev. | S - Sale+OE | $17.12 | -6,000 | 0 | -100% | -$102,728 | |||||
2022-05-06 | PEPG | Keating Laurie | Dir | P - Purchase | $12.00 | +4,166 | 4,166 | New | +$49,992 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |